DR

Darshan Ramchandra Malusare

Active Director Alternate Director DIN 11013885
DIN 11013885 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Darshan Ramchandra Malusare

Data last updated:

Darshan Ramchandra Malusare is an Alternate Director at Ele Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 11013885
Primary Designation Alternate Director
Industry Pharma
First Appointment 21 Mar 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ele Pharma Private Limited U46497GJ2022PTC133262
Alternate Director21 Mar 20252022Active

Board colleagues of Darshan Ramchandra Malusare

Directorship timeline

Open interactive timeline →
Ele Pharma Private Limited
Premium access

Shareholding and investment profile for Darshan Ramchandra Malusare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Darshan Ramchandra Malusare

Darshan Ramchandra Malusare currently holds 1 directorship: Ele Pharma Private Limited (Alternate Director, since 21 Mar 2025).

Darshan Ramchandra Malusare was first appointed on 21 Mar 2025 as Alternate Director at Ele Pharma Private Limited.

The current boards of Darshan Ramchandra Malusare's companies include Asseel Harith Kamal Al Ani (Ele Pharma Private Limited), Marwan Jinan Yousif Bethoon (Ele Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available